Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study-Reference-Cited by-同舟云学术

Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

Published:2010-10 Issue:5 Volume:17 Page:491-501
ISSN:1741-8267
Container-title:European Journal of Cardiovascular Prevention & Rehabilitation
language:en
Short-container-title:European Journal of Cardiovascular Prevention & Rehabilitation

Author:

Friis-Møller Nina¹,Thiébaut Rodolphe²,Reiss Peter³,Weber Rainer⁴,D'Arminio Monforte Antonella⁵,De Wit Stephane⁶,El-Sadr Wafaa⁷,Fontas Eric⁸,Worm Signe¹,Kirk Ole¹,Phillips Andrew⁹,Sabin Caroline A.¹⁰,Lundgren Jens D.¹,Law Matthew G.⁹,

Affiliation:

1. Copenhagen HIV Programme (CHIP), University of Copenhagen/Faculty of Health Science, Copenhagen, Denmark

2. Aquitaine, INSERM, ISPED, Université Victor Segalen Bordeaux, Bordeaux

3. ATHENA, HIV Monitoring Foundation, Academic Medical Center, Amsterdam, The Netherlands

4. SHCS, Division of Infectious Diseases and Hospital Epidemiolog, Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland

5. ICONA, Hospital San Paolo, University of Milan, Italy

6. Saint-Pierre Cohort, CHU Saint-Pierre Hospital, Brussels, Belgium

7. CPCRA, Columbia University/Harlem Hospital, New York, USA

8. Nice Cohort, CHU Nice Hopital de l'Archet, Nice, France

9. Royal Free Centre for HIV Medicine and Department of Primary Care and Population Sciences, Royal Free and University College, London, UK

10. AHOD, National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

http://journals.sagepub.com/doi/pdf/10.1097/HJR.0b013e328336a150

Reference44 articles.

1. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men

2. Protease inhibitors and cardiovascular outcomes in patients with HIV-1

3. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients

4. Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

5. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Four Predictive Scores for Cardiovascular Risk in Mexican People with HIV;AIDS Research and Human Retroviruses;2024-07-01

2. Clinical Outcomes After Acute Coronary Syndromes or Revascularization Among People Living With HIV;JAMA Network Open;2024-05-14

3. The dynamic risk factors of cardiovascular disease among people living with HIV: a real-world data study;BMC Public Health;2024-04-25

4. Predictive model and risk analysis for coronary heart disease in people living with HIV using machine learning;BMC Medical Informatics and Decision Making;2024-04-25

5. Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas;Life;2024-03-28